0001603018-15-000001.txt : 20150928 0001603018-15-000001.hdr.sgml : 20150928 20150928170601 ACCESSION NUMBER: 0001603018-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150928 DATE AS OF CHANGE: 20150928 EFFECTIVENESS DATE: 20150928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alexza Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001344413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770567768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-248343 FILM NUMBER: 151128080 BUSINESS ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650.944.7000 MAIL ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 D 1 primary_doc.xml X0707 D LIVE 0001344413 Alexza Pharmaceuticals Inc. 2091 STIERLIN COURT MOUNTAIN VIEW CA CALIFORNIA 94043 650.944.7000 DELAWARE None None Corporation true Thomas B King 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Executive Officer Director Mark K Oki 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Executive Officer Edwin S Kamemoto 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Executive Officer J Kevin Buchi 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Deepika R Pakianathan 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director J Leighton Read 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Gordon Ringold 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Isaac Stein 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Joseph L Turner 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Director Pharmaceuticals Decline to Disclose 06b false 2015-09-28 false true false 0 143750 143750 0 Represents the issuance of shares as partial consideration for a term loan in the maximum principal amount of $5 million with an interest rate of 6% per annum as reported by the Company in Current Report on Form 8-K on the date hereof. false 1 0 0 0 true false Alexza Pharmaceuticals Inc. /s/ Mark K. Oki Mark K. Oki SVP & CFO 2015-09-28